Publications 2018

AIDS-defining Cancer Project Working Group of IeDEA COHERE in EuroCoord. Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS. 2018;32(18):2777‑86. Disponible sur:

Caniglia EC, Phillips A, Porter K, Sabin CA, Winston A, Logan R, et al. Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions. J Acquir Immune Defic Syndr. 1 janv 2018;77(1):102‑9. Disponible sur:

de Monteynard L-A, Matheron S, Grabar S, de Truchis P, Gilquin J, Pavie J, et al. Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France. PLoS One. 1 oct 2018;13(10):e0205385. Disponible sur:

Hughes RA, May MT, Tilling K, Taylor N, Wittkop L, Reiss P, et al. Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio. AIDS. 19 juin 2018;32(10):1361‑7. Disponible sur:

IeDEA and COHERE Cohort Collaborations. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clin Infect Dis. 5 mars 2018;66(6):893‑903. Disponible sur:

Melliez H, Mary-Krause M, Bocket L, Guiguet M, Abgrall S, De Truchis P, et al. Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4). Clin Infect Dis. 2 juill 2018;67(2):275‑82. Disponible sur:

Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? HIV Med. 1 janv 2018;19(1):42‑8. Disponible sur:

Panayidou K, Davies M-A, Anderegg N, Egger M, IeDEA, COHERE P and I 219C CWG. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation. J Int AIDS Soc. 1 nov 2018;21(11):e25200. Disponible sur:

Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, et al. Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation. J Int AIDS Soc. 1 janv 2018;21(1). Disponible sur:

Potard V, Goujard C, Valantin MA, Lacombe JM, Lahoulou R, Chéret A, et al. Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens. BMC Infect Dis. 11 juill 2018;18(1):326. Disponible sur:

Roul H, Mary-Krause M, Ghosn J, Delaugerre C, Pialoux G, Cuzin L, et al. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era. AIDS. 13 nov 2018;32(17):2605‑14. Disponible sur:

Stirrup OT, Copas AJ, Phillips AN, Gill MJ, Geskus RB, Touloumi G, et al. Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion. HIV Med. 1 mars 2018;19(3):184‑94. Disponible sur: